Cargando…
Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia
The COVID-19 pandemic has resulted in significant morbidity and mortality worldwide. In order to prevent severe infection, mass COVID-19 vaccination campaigns with several vaccine types are currently underway. We report pathological and immunological findings in eight patients who developed vaccine-...
Autores principales: | Althaus, Karina, Möller, Peter, Uzun, Günalp, Singh, Anurag, Beck, Annika, Bettag, Martin, Bösmüller, Hans, Guthoff, Martina, Dorn, Franziska, Petzold, Gabor C., Henkes, Hans, Heyne, Nils, Jumaa, Hassan, Kreiser, Kornelia, Limpach, Caroline, Luz, Beate, Maschke, Matthias, Müller, Janis A., Münch, Jan, Nagel, Simon, Pötzsch, Bernd, Müller, Jens, Schlegel, Christoph, Viardot, Andreas, Bäzner, Hansjörg, Wolf, Marc, Pelzl, Lisann, Warm, Verena, Willinek, Winfried A., Steiner, Jochen, Schneiderhan-Marra, Nicole, Vollherbst, Dominik, Sachs, Ulrich J., Fend, Falko, Bakchoul, Tamam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327736/ https://www.ncbi.nlm.nih.gov/pubmed/34011137 http://dx.doi.org/10.3324/haematol.2021.279000 |
Ejemplares similares
-
Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2022) -
Antibody-induced procoagulant platelets in severe COVID-19 infection
por: Althaus, Karina, et al.
Publicado: (2021) -
The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2021) -
Antibody‐mediated procoagulant platelet formation in COVID‐19 is AKT dependent
por: Pelzl, Lisann, et al.
Publicado: (2022) -
Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
por: Zlamal, Jan, et al.
Publicado: (2023)